Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
FranceStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
FranceStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
FranceStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
FranceStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
FranceStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
FranceLong-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
FranceStudy of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation
FranceStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
FranceStudy of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation
FranceStudy of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
